Odyssey Health (ODYY) Net Margin (2014 - 2016)

Odyssey Health (ODYY) posted Net Margin of 246.36% for Q3 2016, down 577.3% on a QoQ basis from 36.37% in Q2 2016.

Analysis

Odyssey Health (ODYY) Net Margin (2014 - 2016) Analysis & Trends

Odyssey Health has reported Net Margin for 3 years, with the latest figure at 246.36% in Q3 2016.

On a quarterly basis, Net Margin changed N/A year-over-year to 246.36% in Q3 2016; TTM through Apr 2017 was 1136.24%, a 81028.0% decrease from a year earlier, with the FY2016 full-year figure at 229.94%, down 16746.0% from the prior year.
Net Margin was 246.36% for Q3 2016 at Odyssey Health, down from 36.37% in the prior quarter.
The five-year high for Net Margin was 31.44% in Q4 2014, with the low at 246.36% in Q3 2016.
Average Net Margin over 3 years is 120.09%, with a median of 50.2% recorded in 2015.
The largest YoY upside for Net Margin was 19972 bps in 2016 against a maximum downside of 19972 bps in 2016.
Over 3 years, Net Margin stood at 31.44% in 2014, then slumped by 651 bps to 236.09% in 2015, then declined by 4 bps to 246.36% in 2016.
The last three Net Margin figures came in at 246.36% (Q3 2016), 36.37% (Q2 2016), and 236.09% (Q2 2015), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Abbott Laboratories	184.22 Bn	178.62 Bn	7.27 Bn	7.37%
2	Intuitive Surgical	124.47 Bn	119.26 Bn	1.96 Bn	28.46%
3	Medtronic	118.41 Bn	109.59 Bn	6.34 Bn	15.17%
4	Stryker	105.06 Bn	101.58 Bn	4.50 Bn	19.37%
5	Boston Scientific	66.48 Bn	65.94 Bn	3.85 Bn	16.67%
6	Edwards Lifesciences	49.76 Bn	45.51 Bn	1.35 Bn	13.87%
7	Alcon	33.93 Bn	32.47 Bn	1.68 Bn	-
8	Dexcom	32.33 Bn	30.38 Bn	830.00 Mn	19.04%
9	Steris	21.15 Bn	20.67 Bn	684.20 Mn	13.47%
10	Odyssey Health	1.01 Mn	711,880.61	-	-

Historic Data

Download Data